Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis

Table 2 Laboratory examination results, portal diameter and splenic area in antiviral and non-antiviral groups during the study (mean ± SD)

	Non-antiviral	Antiviral	P value
	(n = 38)	(n = 79)
GPT (IU/L)	19.2 ± 53.1	-28.6 ± 58.8	< 0.001
GOT (IU/L)	19.9 ± 52.8	-34.9 ± 86.2	0.001
TB (mmol/L)	3.9 ± 9.6	-3.8 ± 9.5	0.009
ALB (g/L)	-2.8 ± 5.5	1.2 ± 6.1	0.003
PT (s)	1.4 ± 2.2	-0.2 ± 2.1	0.001
PLT (1012/L)	-18.9 ± 28.8	-10.3 ± 16.9	0.029
Diameter of portal vein (mm)	1.0 ± 0.9	0.2 ± 0.8	< 0.001
Splenic section area (cm2)	8.6 ± 7.2	3.6 ± 9.8	0.012

GPT: Glutamic-pyruvic transaminase; GOT: Glutamic-oxaloacetic transaminase; TB: Total bilirubin; ALB: Serum albumin; PT: Prothrombin time; PLT: Platelet count.